Chosen Diagnostics Inc is focused on delivering infant and child healthcare solutions that are safe, dependable, and tailor-made. The company has a breakthrough biomarker that can be used as a molecular diagnostic tool for necrotizing enterocolitis (NEC) in preterm infants.
